Johnson Financial Group, Inc. Amgen Inc Transaction History

Johnson Financial Group, Inc.

$2.19 Billion
Q3 2024

A detailed history of Johnson Financial Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Johnson Financial Group, Inc. holds 12,101 shares of AMGN stock, worth $3.2 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

12,101

Previous 18,126 33.24%

Holding current value

$3.2 Million

Previous $5.66 Million 31.15%

% of portfolio

0.18%

Previous 0.28%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $1.86 Million - $2.03 Million	-6,025 Reduced 33.24%	12,101 $3.9 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $2.15 Million - $2.61 Million	8,167 Added 82.01%	18,126 $5.66 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $78,778 - $95,096	293 Added 3.03%	9,959 $2.83 Million
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $537,992 - $606,919	-2,104 Reduced 17.88%	9,666 $2.78 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $92,270 - $114,556	422 Added 3.72%	11,770 $3.16 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $14,356 - $16,975	-67 Reduced 0.59%	11,348 $2.52 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $288,333 - $351,430	1,277 Added 12.6%	11,415 $2.76 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $143,372 - $182,172	-626 Reduced 5.82%	10,138 $2.66 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $1.09 Million - $1.23 Million	-4,868 Reduced 31.14%	10,764 $2.89 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $13,150 - $14,634	-57 Reduced 0.36%	15,632 $3.8 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $200,412 - $221,708	914 Added 6.19%	15,689 $3.79 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $207,232 - $237,159	1,042 Added 7.59%	14,775 $3.32 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $139,036 - $162,898	-655 Reduced 4.55%	13,733 $2.92 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $5,605 - $6,219	24 Added 0.17%	14,388 $3.51 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $256,527 - $298,941	-1,156 Reduced 7.45%	14,364 $3.57 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $83,955 - $99,975	388 Added 2.56%	15,520 $3.57 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $415,799 - $462,403	-1,772 Reduced 10.48%	15,132 $3.85 Million
Q2 2020 Aug 11, 2020	SELL	$197.81 - $242.74 $367,728 - $451,253	-1,859 Reduced 9.91%	16,904 $3.99 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $187,160 - $248,225	-1,027 Reduced 5.19%	18,763 $3.8 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $2.61 Million - $3.35 Million	-13,787 Reduced 41.06%	19,790 $4.77 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $121,702 - $145,825	699 Added 2.13%	33,577 $6.5 Million
Q2 2019 Aug 09, 2019	BUY	$166.7 - $195.41 $85,683 - $100,440	514 Added 1.59%	32,878 $6.06 Million
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $243,270 - $274,218	1,345 Added 4.34%	32,364 $6.15 Million
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $350,377 - $409,003	1,964 Added 6.76%	31,019 $6.04 Million
Q3 2018 Nov 09, 2018	BUY	$185.29 - $208.89 $60,219 - $67,889	325 Added 1.13%	29,055 $6.02 Million
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $247,248 - $277,713	-1,489 Reduced 4.93%	28,730 $5.3 Million
Q1 2018 May 07, 2018	BUY	$169.43 - $198.0 $146,556 - $171,270	865 Added 2.95%	30,219 $5.15 Million
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $43,041 - $48,090	255 Added 0.88%	29,354 $5.11 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $4.87 Million - $5.56 Million	29,099	29,099 $5.43 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Johnson Financial Group, Inc. with notifications on news.

Account

Johnson Financial Group, Inc. Amgen Inc Transaction History